Malawi national action plan on antimicrobial resistance

Malawi national action plan on antimicrobial resistance PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 924005684X
Category : Medical
Languages : en
Pages : 34

Get Book Here

Book Description

Malawi national action plan on antimicrobial resistance

Malawi national action plan on antimicrobial resistance PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 924005684X
Category : Medical
Languages : en
Pages : 34

Get Book Here

Book Description


Implementing the global action plan on antimicrobial resistance

Implementing the global action plan on antimicrobial resistance PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 924007466X
Category : Medical
Languages : en
Pages : 197

Get Book Here

Book Description


Antimicrobial Resistance in Developing Countries

Antimicrobial Resistance in Developing Countries PDF Author: Aníbal de J. Sosa
Publisher: Springer Science & Business Media
ISBN: 0387893709
Category : Science
Languages : en
Pages : 553

Get Book Here

Book Description
Avoiding infection has always been expensive. Some human populations escaped tropical infections by migrating into cold climates but then had to procure fuel, warm clothing, durable housing, and crops from a short growing season. Waterborne infections were averted by owning your own well or supporting a community reservoir. Everyone got vaccines in rich countries, while people in others got them later if at all. Antimicrobial agents seemed at first to be an exception. They did not need to be delivered through a cold chain and to everyone, as vaccines did. They had to be given only to infected patients and often then as relatively cheap injectables or pills off a shelf for only a few days to get astonishing cures. Antimicrobials not only were better than most other innovations but also reached more of the world’s people sooner. The problem appeared later. After each new antimicrobial became widely used, genes expressing resistance to it began to emerge and spread through bacterial populations. Patients infected with bacteria expressing such resistance genes then failed treatment and remained infected or died. Growing resistance to antimicrobial agents began to take away more and more of the cures that the agents had brought.

Global Antimicrobial Resistance Surveillance System

Global Antimicrobial Resistance Surveillance System PDF Author: World Health Organization
Publisher:
ISBN: 9789241549400
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
"In May 2015, the Sixty-eighth World Health Assembly adopted the Global action plan on antimicrobial resistance, which reflects the global consensus that AMR poses a profound threat to human health. One of the five strategic objectives of the Global action plan is to strengthen the evidence base through enhanced global surveillance and research. The Global Antimicrobial Resistance Surveillance System (GLASS) has been developed to facilitate and encourage a standardized approach to AMR surveillance globally and in turn support the implementation of the Global action plan on antimicrobial resistance. This manual addresses the early phase of implementation of GLASS, focussing on surveillance of resistance in common human bacterial pathogens. The intended readership of this publication is public health professionals and health authorities responsible for national AMR surveillance. It outlines the GLASS standards and describes the road map for implementation of the system between 2015 and 2019. Further development of GLASS will be based on the lessons learnt during this period"--Publisher's description.

Challenges to Tackling Antimicrobial Resistance

Challenges to Tackling Antimicrobial Resistance PDF Author: Michael Anderson
Publisher: Cambridge University Press
ISBN: 1108799450
Category : Health & Fitness
Languages : en
Pages : 273

Get Book Here

Book Description
An accessible overview of the challenges in tackling AMR, and the economic and policy responses of the 'One Health' approach. It will appeal to policy-makers seeking to strengthen national and local polices tackling AMR, as well as students and academics who want an overview of the latest scientific evidence regarding effective AMR policies.

Steering Against Superbugs

Steering Against Superbugs PDF Author: Olivier Rubin
Publisher: Oxford University Press
ISBN: 0192899473
Category : Drug resistance
Languages : en
Pages : 307

Get Book Here

Book Description
"Many people correctly understand that superbugs can threaten health. Superbugs are microbial organisms, including bacteria, viruses, parasites, or fungi, that resist one or more antibiotic or other antimicrobial treatments. What may be less widely understood is that the threat is global, growing, and encompasses human systems surrounding healthcare, agriculture, and the environment. In 2019, 1.3 million people around the world are estimated to have died from resistant microbes (Murray et al., 2022). This is similar to how many succumb annually to HIV/AIDS and Malaria combined (Laxminarayan, 2022). The recent coronavirus pandemic may have further exacerbated the global health challenge posed by superbugs (Rizvi & Ahammad, 2022; Adebisi et al., 2021; Rodríguez-Baño et al., 2021). By 2050, worst-case projections include annual superbug fatalities of ten million people (O'Neil, 2016). Some experts have started to refer to the increase and spread of superbugs as the overlooked or silent pandemic (Laxminarayan, 2022; UN, 2020; Mahoney et al., 2021). Other experts warn that we might be heading towards a 'post-antibiotic' era where minor infections become increasingly severe or even impossible to treat (Reardon, 2014; Kwon & Powderly, 2021). Annual economic losses related to superbugs are already estimated in the tens of billion U.S. dollars (Hall, McDonell & O'Neil, 2018). As a response to these global challenges, this book analyses and discusses ways to reduce barriers to and create opportunities for global governance of antimicrobial resistance. Or more briefly, steering against superbugs"--

Chikungunya Virus

Chikungunya Virus PDF Author:
Publisher: BoD – Books on Demand
ISBN: 1839690895
Category : Medical
Languages : en
Pages : 104

Get Book Here

Book Description
The chikungunya virus (CHIKV) is an RNA virus that is transmitted to humans by Aedes mosquitos commonly found in tropical and subtropical countries. In humans, CHIKV causes an infection with symptoms strikingly like those of the dengue virus and Zika disease, both of which are also transmitted to humans by the same genus of mosquitos. This book delves into the history of the disease and the molecular characterization of the virus. It sheds light on modern diagnosis tools that allow unambiguous identification of CHIKV infection. In addition, this book addresses the epidemiology of chikungunya fever, the distribution and spread of the disease, and the promising approaches under consideration for preventing and treating the disease.

Global antimicrobial resistance and use surveillance system (GLASS) report 2021

Global antimicrobial resistance and use surveillance system (GLASS) report 2021 PDF Author:
Publisher: World Health Organization
ISBN: 9240027335
Category : Medical
Languages : en
Pages : 180

Get Book Here

Book Description
The GLASS Report 2021 highlights the new GLASS technical module on antimicrobial consumption surveillance, GLASS-AMC, and summarizes the results of the 2020 AMR and AMC data calls. It also describes the status of development of GLASS activities and WHO AMR-related activities globally and regionally.

Saving Lives, Buying Time

Saving Lives, Buying Time PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309165938
Category : Medical
Languages : en
Pages : 384

Get Book Here

Book Description
For more than 50 years, low-cost antimalarial drugs silently saved millions of lives and cured billions of debilitating infections. Today, however, these drugs no longer work against the deadliest form of malaria that exists throughout the world. Malaria deaths in sub-Saharan Africaâ€"currently just over one million per yearâ€"are rising because of increased resistance to the old, inexpensive drugs. Although effective new drugs called "artemisinins" are available, they are unaffordable for the majority of the affected population, even at a cost of one dollar per course. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance examines the history of malaria treatments, provides an overview of the current drug crisis, and offers recommendations on maximizing access to and effectiveness of antimalarial drugs. The book finds that most people in endemic countries will not have access to currently effective combination treatments, which should include an artemisinin, without financing from the global community. Without funding for effective treatment, malaria mortality could double over the next 10 to 20 years and transmission will intensify.

Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level

Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level PDF Author: World Health Organization
Publisher:
ISBN: 9789241549929
Category : Medical
Languages : en
Pages : 92

Get Book Here

Book Description
Health care-associated infections (HAI) are one of the most common adverse events in care delivery and a major public health problem with an impact on morbidity, mortality and quality of life. At any one time, up to 7% of patients in developed and 10% in developing countries will acquire at least one HAI. These infections also present a significant economic burden at the societal level. However, a large percentage are preventable through effective infection prevention and control (IPC) measures. These new guidelines on the core components of IPC programmes at the national and facility level will enhance the capacity of Member States to develop and implement effective technical and behaviour modifying interventions. They form a key part of WHO strategies to prevent current and future threats from infectious diseases such as Ebola, strengthen health service resilience, help combat antimicrobial resistance (AMR) and improve the overall quality of health care delivery. They are also intended to support countries in the development of their own national protocols for IPC and AMR action plans and to support health care facilities as they develop or strengthen their own approaches to IPC. These are the first international evidence-based guidelines on the core components of IPC programmes. These new WHO guidelines are applicable for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.